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Nucleus Accumbens Shell and mPFC
but Not Insula Orexin-1 Receptors
Promote Excessive Alcohol Drinking
Kelly Lei, Scott A. Wegner, Ji Hwan Yu, Arisa Mototake, Bing Hu and Frederic W. Hopf *
Alcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA,
USA
Addiction to alcohol remains a major social and economic problem, in part because of
the high motivation for alcohol that humans exhibit and the hazardous binge intake this
promotes. Orexin-1-type receptors (OX1Rs) promote reward intake under conditions of
strong drives for reward, including excessive alcohol intake. While systemic modulation of
OX1Rs can alter alcohol drinking, the brain regions that mediate this OX1R enhancement
of excessive drinking remain unknown. Given the importance of the nucleus accumbens
(NAc) and anterior insular cortex (aINS) in driving many addictive behaviors, including
OX1Rs within these regions, we examined the importance of OX1Rs in these regions
on excessive alcohol drinking in C57BL/6 mice during limited-access alcohol drinking
in the dark cycle. Inhibition of OX1Rs with the widely used SB-334867 within the
medial NAc Shell (mNAsh) significantly reduced drinking of alcohol, with no effect on
saccharin intake, and no effect on alcohol consumption when infused above the mNAsh.
In contrast, intra-mNAsh infusion of the orexin-2 receptor TCS-OX2-29 had no impact on
alcohol drinking. In addition, OX1R inhibition within the aINS had no effect on excessive
drinking, which was surprising given the importance of aINS-NAc circuits in promoting
alcohol consumption and the role for aINS OX1Rs in driving nicotine intake. However,
OX1R inhibition within the mPFC did reduce alcohol drinking, indicating cortical OXR
involvement in promoting intake. Also, in support of the critical role for mNAsh OX1Rs,
SBwithin themNAsh also significantly reduced operant alcohol self-administration in rats.
Finally, orexin ex vivo enhanced firing in mNAsh neurons from alcohol-drinking mice, with
no effect on evoked EPSCs or input resistance; a similar orexin increase in firing without
a change in input resistance was observed in alcohol-naïve mice. Taken together, our
results suggest that OX1Rs within the mNAsh and mPFC, but not the aINS, play a central
role in driving excessive alcohol drinking.
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INTRODUCTION
Addiction to abused substances, including alcohol, is characterized by strong motivation
for the addictive substance (Larimer et al., 1999; Sinha, 2009; Koob and Volkow, 2010).
However, despite extensive efforts, alcohol use disorders (AUDs) remain a significant
problem with substantial personal, social, and economic costs (Harwood et al., 1998;
Blincoe et al., 2002; Mokdad et al., 2004; Dawson et al., 2005; Hingson et al., 2005;
Rehm et al., 2009; Bouchery et al., 2011; Sacks et al., 2013; CDC, 2014; SAMHSA, 2014),
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especially because of the limited pharmacotherapies that are
effective against AUDs (Spanagel, 2009; WHO, 2014).
Orexin receptors (OXRs) are of particular interest for
addictive behaviors since they can promote intake of a number
of motivating and addictive substances (Mahler et al., 2012,
2014; Boutrel et al., 2013; Barson and Leibowitz, 2016). OXRs
are activated by the neuropeptide orexin, which is synthesized
in a subset of cells in the lateral hypothalamus that project
throughout the brain (de Lecea et al., 1998), and mediate a
variety of regulatory and homeostatic behaviors ranging from
sleep-wake cycle and neuroendocrine regulation to feeding and
arousal (Mahler et al., 2014; Brown J. A. et al., 2015; Li et al.,
2016). Orexin can act through OX1-type or OX2-type receptors
(OX1Rs or OX2Rs), and although both receptors can contribute
to addictive behaviors (Mahler et al., 2012), existing studies
suggest that OX1Rs play a much more important overall role
relative to OX2Rs (Moorman and Aston-Jones, 2009; Baimel
et al., 2014; Barson et al., 2014; Mahler et al., 2014; Brown J. A.
et al., 2015; but see Brown et al., 2013; Anderson et al., 2014). In
particular, OX1Rs have been implicated in driving the pursuit and
intake of high-value, salient natural rewards, such as sucrose and
high-fat foods, as well as addictive substances such as cocaine,
opioids, nicotine, and alcohol, with little role in sustaining
consumption of less motivating substances (Borgland et al., 2009;
Cason et al., 2010; Baimel et al., 2014; Mahler et al., 2014). For
example, OX1Rs mediate greater alcohol preference and intake
in rats (Moorman and Aston-Jones, 2009) and increased alcohol
drinking in dependent mice (Lopez et al., 2016). Thus, OX1R
signaling could represent an important and novel clinical and
therapeutic target for intervention for AUDs (Khoo and Brown,
2014; Li et al., 2016).
While considerable evidence implicates OX1Rs in driving
intake of preferred rewards, the brain regions that mediate this
effect on alcohol drinking are poorly understood. We recently
demonstrated that projections from the anterior insula (aINS) to
the nucleus accumbens (NAc) are critical for driving compulsion-
like alcohol drinking in rats (Seif et al., 2013). The medial Shell
subregion of the NAc (mNAsh) also plays an important role in a
promoting a number of addictive and other motivated behaviors
(Anderson et al., 2008; Chaudhri et al., 2010; Saddoris et al.,
2013; Castro et al., 2015; Corbit and Balleine, 2015; Marchant
et al., 2015; Millan et al., 2015), including a role for mNAsh
OXRs during feeding and morphine-related behavior (Thorpe
andKotz, 2005; Qi et al., 2013; Sadeghzadeh et al., 2016), although
there have been mixed results regarding the presence of OX1Rs
within the mNAsh (See Section Discussion). The aINS is also
thought to play a central role in driving addictive behaviors in
both humans (Naqvi et al., 2014) and animals (Hollander et al.,
2008; Seif et al., 2013), and OX1Rs within the aINS promote
nicotine intake (Hollander et al., 2008). In addition, OX1Rs in
the mPFC have been shown to increase alcohol relapse (Brown
R. M. et al., 2015). Thus, we examined whether OX1Rs in the
mNAsh, aINS, and mPFC were important for driving excessive
alcohol drinking in mice, and whether mNAsh OX1Rs promoted
responding for alcohol in rats. We also used electrophysiology
to assess whether OX1Rs altered measures of mNAsh activity
ex vivo.
METHODS
Animals
All procedures followed the Guide for Care and Use of
Laboratory Animals provided by the National Institutes of
Health, and with approval of the Institutional Animal Care and
Use Committee of UCSF. Male C57BL/6 mice, 7–8-week of age,
were purchased from Jackson Laboratories. Mice were single-
housed under a reverse 12:12 light:dark cycle, with lights off
at 10:00 a.m. Male Long-Evans rats, 45–50 days of age, were
purchased from Harlan and singly housed, and housed under a
standard light-dark cycle (with drinking experiments performed
in the light cycle). Food and water were available, ad libitum,
for all subjects. We used mice because of their higher level of
drinking under two-bottle intake relative to rats. In contrast,
operant methods in mice are much more challenging, and thus
we utilized operant methods in rats.
Limited Daily Access (LDA) to Alcohol in
Mice
The repeated, limited access choice alcohol drinking model
was modified from that previously described (Lesscher et al.,
2010; Kasten and Boehm, 2014). Mice were first acclimated
to housing conditions for 2-week. Mice were then given two-
bottle choice access to one bottle with 15% alcohol (v/v)
in water and a second bottle of water. Mice first had a
24-h overnight alcohol-drinking session, followed by a 24-
h withdrawal period. Thereafter, mice were presented daily
with 15% alcohol and water for 2-h, Monday–Friday, in their
home cage, with drinking sessions starting 3-h into the dark
cycle. This excessive-drinking exposure paradigm leads to binge
levels of alcohol drinking (>80 mg%) (Lei et al., 2016). In
order to control for side preference, the bottle placements of
the solutions were alternated between each drinking session.
Intake level was measured by determining bottle weight and
corrected for spill, which was determined by separate spill-
control bottles.
Saccharin Intake in Mice
Drinking of a 0.05% saccharin solution under two-bottle choice
was performed using a schedule identical to that used for alcohol.
This concentration was determined to give approximately the
same volume of intake as alcohol (e.g., 19.2 ± 2.3ml/kg/2-h of
alcohol intake for vehicle condition in Figure 1B; t(1, 27) = 1.54,
p = 0.14 vs. volume of saccharin intake for vehicle condition in
Figure 2B).
Alcohol Self-administration in Rats
Rat self-administration methods were identical to those
previously described (Simms et al., 2011b), using standard
operant conditioning chambers (MedAssociates). Briefly, rats
underwent six 14-h overnight session on an FR1 schedule, with
0.1ml of 20% alcohol delivered after each FR1 press. During
overnight training, only the active lever was available, which
allowed the establishment of lever-pressing behavior. Rats then
had six sessions of 45-min FR1, and then were moved to a
daily 30-min FR3 schedule of responding; a second, inactive
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FIGURE 1 | OX1R blockade within the medial NAc Shell significantly
reduced alcohol drinking in mice. (A) Locations of cannulae shown by gray
circles; sections at approximately AP +1.34, +1.18 and +0.98mm relative to
Bregma. (B) Infusion of 3-µg SB within the mNAsh decreased alcohol intake.
(C,D) No changes in (C) alcohol preference or (D) concurrent water intake.
Preference was calculated as (ml alcohol)/(ml alcohol + ml water). *p < 0.05.
lever was also introduced during the FR3 sessions. In all phases
of training, successful completion of an FR response resulted
in alcohol delivery as well as a cue light above the active
lever and a tone. Inactive lever presses were not accompanied
by alcohol delivery or light or tone cues. Rats pressed for a
minimum of 20 sessions before testing the impact of SB on
responding for alcohol. Any animal receiving less 0.3 g/kg
ethanol intake per session were excluded (one rat in this
study).
Cannula Implantation Surgeries
In mice, after ∼2-week of LDA, surgery was performed to
implant bilateral guide cannulae (Plastics One) aimed at the
mNAsh (AP +1.5, ML ±0.5, DV −4.5mm), an offsite control
region above the mNAsh (AP +1.5, ML ±0.5, DV −3.0mm),
aINS (AP +2.0, ML ±2.4, DV −2.0mm), and the mPFC
(attempting to target the infralimbic) (AP +1.7, ML ±0.4, DV
−2.7mm). In rats, after establishing FR3 responding, bilateral
guide cannulae were implanted targeting the mNAsh (AP +1.8,
ML ±0.8, DV −6.5mm). All coordinates are given relative to
Bregma. After surgery, animals were allowed to recover for
1-week before resuming alcohol drinking sessions, and handling
for drug microinfusions began the week after. After completion
of drug treatments, brains were harvested for verification of
cannula placement.
FIGURE 2 | mNAsh OX1R blockade did not alter saccharin drinking. (A)
Locations of cannulae, as for Figure 1. (B–D) Infusion of 3-µg SB within the
mNAsh did not alter (B) saccharin intake, (C) preference or (D) concurrent
water intake.
Drug Microinfusions
SB-334867 (SB, Tocris), a selective OX1R antagonist, was
dissolved in 100% DMSO vehicle (Simms et al., 2011a). Mice
received microinjections of either vehicle or 3-µg/200 nL/side
(47 nmol) of SB 30-min prior to an alcohol-drinking session,
or 3-µg/200 nL/side (59 nmol) of the OX2R antagonist TCS-
OX2-29 (TCS, Tocris); these are relatively high doses but have
previously been utilized (Borgland et al., 2006; Qi et al., 2013;
Brown R. M. et al., 2015). Drugs were injected with bilateral
infusion needles (Plastics One) that projected 0.3mm past the
end of the guide cannulae, at a rate of 200 nL/min. Needles
were left in place for an extra 1-min before retraction. Each
dose (vehicle and 3-µg SB or TCS) was microinjected twice (on
different test days) and counter-balanced across treatment and
animals.
Rats received microinjections of either 0- or 3-µg/600 nL/side
of SB, on different days using a within-animal design in a counter-
balance manner, 30-min prior to alcohol self-administration
sessions. Drugs were injected 600 nL/min via bilateral infusions
needles (Plastics One) that project 1-mm beyond the guide
cannulae. Needles were left in place for an extra 90-s.
Mice or rats were given at least 1 day of alcohol or saccharin
drinking between test days.
Alcohol intake, especially bottle drinking, can be influenced
by handling (Lum et al., 2014), and thus it is important to
give animals a period of time after injection to remove possible
confounds of handling on alcohol drinking, and we used a 30min
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time point between drug injection and behavioral testing. Thus,
given the use of DMSO as a vehicle for SB, we cannot completely
rule out the possibility that this period of timemight have allowed
greater diffusion of OXRS to adjacent brain regions, for example
into the adjacent NAcore. However, even if a briefer time was
used between injection and initiation of alcohol drinking, the
drinking sessions were 2 h and any such issues related to diffusion
would become apparent within the first hour of drinking. Also,
although we do not have specific information about the level
of spread of our infusate, 200 nl has previously used as an
microinjection volume for studies distinguishing mNAsh vs.
NAcb Core in mice (Managò et al., 2008), and is widely used as
a volume for injection for other studies in mice (e.g., Stratford
and Wirtshafter, 2011; Kasten and Boehm, 2014; Ramaker et al.,
2015).
DMSO as vehicle could have effects on drinking. However,
alcohol intake in the presence of intra-mNAsh DMSO infusion
was not different from alcohol drinking levels in the uninjected
days adjacent to days with DMSO infusion [DMSO infusion:
2.23 ± 0.28 g/kg; adjacent uninjected days: 2.31 ± 0.23 g/kg;
t(1, 16) = 0.26, p = 0.80; n = 17, determined for the mice
shown in Figure 1, DMSO results are same as shown in Figure 1].
Also, other studies have demonstrated that intracranial injection
of DMSO does not have non-specific effects on behavior relative
to saline injection (e.g., Naghdi and Asadollahi, 2004). Thus, the
DMSO vehicle itself likely did not have non-specific effects on
alcohol drinking.
Brain Slice Preparation and Ex vivo
Electrophysiology
Slice preparation and electrophysiology methods were similar to
those previously described (Seif et al., 2011, 2013; Pomrenze et al.,
2015). Briefly, adult mice were anesthetized with pentobarbital
(100mg/kg), decapitated, and brain slices were cut in an ice-
cold glycerol-based solution (in mM: 252 glycerol, 2.5 KCl, 1.25
NaH2PO4, 1 MgCl2, 2 CaCl2, 25 NaHCO3, 1 L-ascorbate, and
11 glucose, bubbled with carbogen) (Pomrenze et al., 2015).
Slices recovered at 32◦C in carbogen-bubbled aCSF (containing,
in mM: 126 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4
CaCl2, 18 NaHCO3, 11 glucose, pH 7.2–7.4, mOsm 302–305)
for at least 30min before experiments, with 1mM ascorbic acid
added just before the first slice. During experiments, slices were
submerged and perfused (2ml/min) with aCSF, 31–32◦C, with
CNQX (10µM) and picrotoxin (50µM). Action potential firing
and EPSCs were recorded using Clampex 10.1 and an Axon
700 A patch amplifier (Axon Instruments, Foster City, CA). All
experiments were performed using whole-cell recording using
visualized infrared-DIC with 2.5–3.5M electrodes.
Firing and input resistance were measured using a potassium-
methanesulfonate based internal solution (in mM: 130 KOH,
105 methanesulfonic acid, 17 HCl, 20 HEPES, 0.2 EGTA, 2.8
NaCl, 2.5mg/ml Mg-ATP, 0.25mg/ml GTP, pH 7.2–7.4, 278–287
mOsm). DC current was passed to bring each neuron to ∼-
85mV before starting firing experiments. Rheobase (minimum
current needed to generate firing) was first identified for each
cell by a series of 500ms current steps, increasing in 20 pA
increments, which was then terminated once rheobase was
identified. We then began experiments where a more restricted
set of 500ms current steps (6–7 steps, 20 pA apart, with
the first pulse subthreshold for firing) which were repeated
every 30 s to measure possible changes in firing across the
duration of the experiment. Depolarizing pulses alternated
with a 30 pA hyperpolarizing pulse to examine the input
resistance. Changes in firing and input resistance with 10min
of orexinA application (100 nM) was determined after ∼15min
baseline, with SB added 5min before orexinA exposure in
some cells.
To determine orexinA-related changes in firing, we averaged
7min of baseline, and averaged the last 7min of the 10-
min orexinA exposure (since it usually takes 2–3min before a
drug effect is clear); we then subtracted the average number
of action potentials generated during orexinA exposure from
average number of spikes at baseline. This was determined at
rheobase, the minimum current where firing was evoked, and
at the current step above rheobase. Rheobase was 168 ± 24
pA (range: 100–320 pA) for experiments from alcohol-drinking
mice, and 185 ± 22 pA (range: 125–240 pA) for alcohol-naïve
experiments.
EPSCs were measured using a cesium-methanesulfonate
based internal solution (in mM: 120 cesium methanesulfonate,
20 HEPES, 0.4 EGTA, 2.8 NaCl, 5 TEA chloride, 2.5 Mg-
ATP, 0.25 Na-GTP, pH 7.2–7.3, 270–285 mOsm). EPSCs were
filtered at 2 kHz and digitized at 10 kHz. Series resistance (10-
30 M) and input resistance were monitored on-line using a
4-mV depolarizing step (50ms) which was given after every
EPSC. Electrically-evoked currents were elicited using a bipolar
stimulating electrode placed ∼200µM dorsal to the recording
site. As with firing, 7min of baseline and orexinA exposure
were used for determining the percent change in EPSCs with
orexinA.
Statistics for electrophysiology experiments were performed
either using an unpaired t-test, to compare changes in firing
in orexin-exposed neurons with or without SB pre-exposure, or
using a paired t-test, to examine whether orexin exposure altered
input resistance or EPSCs relative to pre-orexin baseline under a
particular condition.
Data Analyses for Behavioral Studies
In mice, after each drinking session, the water and alcohol (or
saccharin) bottles were weighed; subsequently, these values were
used to determine the intake of alcohol (g/kg of body weight)
or saccharin (mL/kg of body weight), as well as water (ml/kg
of body weight) and the preference ratio for the alcohol or
saccharin (volume of reward intake/total volume of reward plus
water intake). Due to variability of two-bottle choice alcohol
drinking in mice, each mouse had two test sessions for vehicle
and two test sessions for OXR blocker, and the average of the two
drinking sessions for each treatment was used for a given animal.
Importantly, all such tests were performed in a counterbalanced
order: a mouse received vehicle vs. drug in a counterbalanced
order for the first two test sessions, such that half the animals
received vehicle in the first session, and the other half received
OXR blocker in the first session. The same counterbalanced order
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was then used for the third and fourth test sessions, to insure
that animals did not receive the same treatment in consecutive
sessions, and to minimize the order effects. Rats received one
test session of vehicle or SB, which was counterbalanced across
animals, and active and inactive lever pressing, rewards received,
and g/kg intake levels, were all determined. Finally, since the
effects of vehicle and drug were tested within the same animal,
all statistics for behavioral experiments were performed using a
paired t-test, using SPSS (IBM). Different behavioral measures
were assessed by separate paired t-tests. All data are shown as
mean± SEM.
In our experience, alcohol intake levels in daily two-bottle
choice sessions are more variable relative to operant responding,
and bottle drinking in mice is more variable than in rat.
Thus, we have adopted the method in mice where vehicle
is tested twice and the two sessions averaged, and a given
agent is tested twice then averaged. In addition, to determine
test-retest variance, we examined the data for intra-mNAsh
vehicle vs. SB during alcohol drinking. We first calculated
the difference between the second-vehicle and first-vehicle test
sessions that an animal underwent, or between the second-
drug and first-drug test sessions. The standard deviation of
test-retest was 2.54 g/kg for vehicle and 1.35 g/kg for SB.
Although the test-retest variability was larger for vehicle, animals
drank an average of 2.23 g/kg alcohol for vehicle sessions
and 1.33 g/kg alcohol for SB sessions. Thus, the somewhat
larger test-retest variability for vehicle sessions may reflect the
larger volume of intake during vehicle sessions. In addition,
to assess order effects, we performed a two-way RM ANOVA
with drug vs. vehicle as one factor and the first vs. second test
session of the given agent as a second factor. There were no
significant effects of first vs. second session [F(1, 32) = 1.647,
p = 0.209], or interaction of session number with group
[vehicle or drug; F(1, 32) = 0.009, p = 0.924], although
there was a significant effect of group [F(1, 32) = 7.602,
p = 0.010], consistent with our previous analysis that SB
in the mNAsh reduced alcohol drinking relative to vehicle.
These findings suggest that there were no differences in intake
between the first and second test sessions for either vehicle
or drug.
One limitation of the present experiments is the possibility
that some experimentsmay be underpowered to observe a change
in intake with OXR blockers, e.g., the trend for intra-mNAsh
SB to decrease in intake in saccharin-consuming mice with
n = 12 vs. n = 17 for alcohol-drinking mice. However,
we were able to observe a significant depression of alcohol
drinking in mice where SB was injected into the mPFC, with
n = 9, suggesting that saccharin-intake experiments were
sufficiently powered to detect any OXR-relate changes. For the
off-site control experiments, it is clear even with n = 6
that there is no impact of SB on alcohol drinking, and if
anything there is a trend for an increase in preference for
alcohol (rather than inhibition of alcohol-related behavior).
Nonetheless, with the smaller sample size, the off-site control
group could be underpowered to detect differences in alcohol
drinking.
RESULT
OX1R Blockade in the Medial NAc Shell
Suppressed Excessive Alcohol Drinking in
Mice
We first examined whether OX1Rs in the mNAsh could
regulate voluntary excessive alcohol drinking. In particular,
we microinjected vehicle or a previously used concentration
of the OX1R-selective antagonist, SB-334867 (SB, 3-µg/side)
(Hollander et al., 2008; Espana et al., 2010; Plaza-Zabala et al.,
2012), prior to an LDA drinking session using a counter-
balanced, within-animal design (n = 17). Our results showed
that inhibition of OX1Rs within the mNAsh (Figure 1A)
significantly decreased alcohol drinking [Figure 1B; t(1, 16) =
2.78, p = 0.013]. No changes were observed in preference
[Figure 1C; t(1, 16) = 0.58, p = 0.57], which likely reflects the
low volume of concurrent water intake during the 2-h alcohol-
drinking sessions [Figure 1D; t(1, 16) = 1.50, p = 0.15; see also
Dhaher et al., 2009; Seif et al., 2015; denHartog et al., 2016]. Thus,
our results suggest that OX1Rs within the mNAsh are important
for driving alcohol drinking.
Suppression of alcohol drinking by theOX1R antagonist in the
mNAsh might represent non-specific changes in motor function
or consumption. Thus, we next examined whether SB within
the mNAsh (Figure 2A) would reduce intake of 0.05% saccharin
(n = 12). However, 3-µg of SB within the mNAsh had no effect
on saccharin consumption [Figure 2B; t(1, 11) = 1.68, p = 0.12],
preference [Figure 2C; t(1, 11) = 0.97, p = 0.35], or concurrent
water intake [Figure 2D; t(1, 11) = 0.77, p = 0.46]. Thus, the
suppression of alcohol drinking when infusing OX1R inhibitors
within themNAshwas likely due to a particular role in promoting
alcohol drinking, rather than through more general regulation of
consumption or activity. However, we do note that there was a
trend for a decrease in saccharin intake with intra-mNAsh SB
infusion.
To assess the possible involvement of OX2Rs in alcohol
drinking, we tested whether injection of the OX2R blocker TCS-
OX2-29 (3-µg) into the mNAsh (Figure 3A; n = 13) would
alter excessive alcohol consumption, similar to what we observed
with intra-mNAsh SB. However, TCS within the mNAsh did not
reduce alcohol intake [Figure 3B; t(1, 12) = 1.94, p = 0.08], and
if anything had a trend to increase intake. TCS within the mNAsh
also did not alter preference [Figure 3C; t(1, 12) = 0.14, p = 0.89]
or concurrent water intake [Figure 3D; t(1, 12) = 1.27, p = 0.23].
These results indicate that OX1Rs but not OX2Rs within the
mNAsh were important for promoting excessive alcohol drinking
in mice.
To test whether SB could affect alcohol drinking by diffusing
and acting in a region adjacent to the mNAsh, we administered
the same dose and vehicle into an off-site control region 1.5-mm
dorsal to the mNAsh (n = 6; Figure 4A). However, no changes
in alcohol intake were observed when 3-µg SB was injected
into the off-site region control group [Figure 4B; t(1, 5) = 0.04,
p = 0.97], and with no change in alcohol preference [Figure 4C;
t(1, 5) = 2.22, p = 0.077] or concurrent water intake [Figure 4D;
t(1, 5) = 1.56, p = 0.18]. Thus, the apparent mNAsh OX1R
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FIGURE 3 | OX2R blockade within the mNAsh did not reduce alcohol
drinking. (A) Locations of cannulae, as for Figure 1. (B–D) Infusion of 3-µg
TCS within the mNAsh did not alter (B) alcohol intake, (C) preference, or (D)
concurrent water intake.
promotion of alcohol drinking was unlikely to reflect action of
SB in brain areas above the mNAsh.
In addition to the mNAsh, the aINS likely plays a central
role in promoting many addiction-related behaviors. Thus, we
also examined whether OX1Rs within the aINS would promote
alcohol drinking (n = 9) (Figure 5A), as was observed for OX1Rs
within themNAsh (Figure 1). However, infusion of SB within the
aINS had no effect on alcohol intake [Figure 5B; t(1, 8) = 0.03,
p = 0.98], preference [Figure 5C; t(1, 8) = 0.17, p = 0.87] or
concurrent water intake [Figure 5D; t(1, 8) = 0.73, p = 0.49].
Thus, contrary to our predictions, OX1Rs within the aINS did
not play a role in promoting alcohol drinking in mice.
Finally, other cortical areas have also been implicated in
regulating alcohol drinking, including the medial prefrontal
cortex. In agreement, we found that infusion of 3-µg SB within
the mPFC (Figure 6A; n = 9) significantly reduced alcohol
drinking [Figure 6B; t(1, 8) = 2.34, p = 0.048], with no impact
on preference [Figure 6C; t(1, 8) = 0.75, p = 0.47] or concurrent
water intake [Figure 6D; t(1, 8) = 1.69, p = 0.13]. Thus, our
results together suggest that mPFC but not aINS OX1Rs are
important for promoting alcohol drinking.
NAsh OX1R Blockade Decreased Lever
Pressing for Alcohol in Rats
Since OX1R inhibition within the mNAsh of mice significantly
reduced alcohol drinking, we next examined whether mNAsh
OX1Rs would be important for promoting alcohol intake under a
FIGURE 4 | OX1R blockade at an off-site control above the mNAsh did
not alter alcohol drinking. (A) Locations of cannulae, as for Figure 1. (B–D)
Infusion of 3-µg SB ∼1.5mM above the mNAsh did not alter (B) alcohol
intake, (C) preference, or (D) concurrent water intake.
different drinking model, operant responding for alcohol in rats
(n = 8) (Figure 7A). In fact, inhibition of OX1Rs within the
mNAsh of rats with 3-µg SB significantly reduced lever-pressing
for alcohol, tested within-rat vs. vehicle [Figure 7B; t(1, 7) =
4.17, p = 0.004], with an ∼40% reduction, similar to what was
observed in mice. OX1R inhibition had no effect on pressing of
the inactive lever [Figure 7C; t(1, 7) = 1.34, p = 0.22], although
this was already very low. In addition, OX1R inhibition within
the mNAsh significantly reduced the number of rewards received
[Figure 7D; t(1, 7) = 2.95, p = 0.021] and the amount of alcohol
consumed [Figure 7E; t(1, 7) = 2.84, p = 0.025]. Thus, OX1Rs in
the mNAsh were critical for promoting alcohol consumption in
both mice and rats.
OrexinA Peptide Enhanced mNAsh Action
Potential Firing through OX1Rs
Since OX1Rs within the mNAsh were important for promoting
alcohol drinking, we next examined whether orexin would
impact mNAsh firing ex vivo in brain slices from adult alcohol-
drinking mice. In fact, firing evoked by depolarizing current
pulses was significantly enhanced in the presence of orexinA
(100 nM, n = 5), which was apparent when analyzing both
at rheobase, the minimum current required to evoke action
potentials in a cell [Figures 8A,B; paired t(4) = 6.54, p =
0.003], and at the current step above rheobase [Figure 8C;
paired t(4) = 5.35, p = 0.006]. Importantly, this effect of
orexinA was prevented by inhibition of OX1Rs with SB [3µM,
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FIGURE 5 | OX1R blockade in the anterior Insular cortex did not alter
alcohol drinking. (A) Locations of cannulae shown by gray circles; sections
at approximately AP +2.22, +2.10, and +1.98mm relative to Bregma. (B–D)
Infusion of 3-µg SB within the aINS did not alter (B) alcohol intake, (C)
preference, or (D) concurrent water intake.
n = 4; Figures 8B,C; orexinA application with vs. without
SB: t(7) = 4.09, p = 0.005 at rheobase; t(7) = 2.91,
p = 0.023 at step above rheobase]. The orexinA increase in
firing was not accompanied by any changes in input resistance,
measured using a hyperpolarizing current pulse at resting
potential [Figures 9A,B; 2.3 ± 2.7% change in R-input; paired
t(4) = 1.26, p = 0.28]. In addition, orexinA did not alter
EPSCs generated at a −70mV resting potential [Figure 9C; n =
6; −3.7 ± 6.5% change in EPSC; paired t(5) = 0.21, p =
0.84]; this EPSC predominantly reflects AMPA receptor currents
(Seif et al., 2013). Together, these results suggest that OX1Rs
enhanced mNAsh activity in alcohol-drinking mice through
altering intrinsic excitability but not glutamatergic function at
−70mV.
We also examined whether orexinA would alter firing in
mNAsh neurons from alcohol-naïve mice. OrexinA (100 nM)
significantly increased action potential firing by 1.6 ± 0.5 spikes
at rheobase [paired t(4) = 3.30, p = 0.03; n = 5], which
was not different from the orexin change in firing in alcohol-
drinking mice [from Figure 8B; unpaired t(8) = 0.01, p =
0.99]. In addition, in agreement with results from alcohol-
drinking mice, the orexin enhancement in firing in alcohol-
naïve mice was not accompanied by any changes in input
resistance [baseline: 307 ± 49 M; orexin: 320 ± 48 M;
4.7 ± 4.6% change in input resistance; paired t(4) = 1.20,
p = 0.30]. Thus, orexin enhanced action potential firing in
FIGURE 6 | OX1R blockade in the mPFC significantly reduced alcohol
drinking. (A) Locations of cannulae shown by gray circles; sections at
approximately AP +1.98, +1.78, and +1.70mm relative to Bregma. (B)
Infusion of 3-µg SB within the mPFC decreased alcohol intake. (C,D) No
changes in (C) alcohol preference or (D) concurrent water intake. *p < 0.05.
mNAsh neurons from both alcohol-naive and alcohol-drinking
mice.
DISCUSSION
Alcohol addiction is a significant economic and social problem,
in part due to the strong motivation for alcohol that persons
with AUDs exhibit. OX1Rs promote intake when there is strong
drive for a reward, but the brain region(s) that mediate the
OX1R promotion of excessive alcohol drinking remain largely
unknown. Here, we demonstrate that the medial NAc Shell
(mNAsh) is a critical region where OX1Rs act to promote
excessive alcohol intake in mice. Inhibition of OX1Rs within
the mouse mNAsh had no effect on consumption of saccharin
or concurrent water drinking during alcohol drinking sessions,
suggesting that mNAsh OX1R regulation of excessive alcohol
intake was not due to nonspecific effects on motor activity
or consumption. In addition, inhibition of OX2Rs within the
mNAsh did not alter alcohol intake, suggesting a receptor-
selective effect within the mNAsh. In addition, OX1R inhibition
at an off-site control region above the mNAsh did not alter
alcohol drinking. Surprisingly, OX1R inhibition within the
mouse aINS also had no effect on excessive alcohol intake
drinking, although aINS-NAc circuits are known to promote
alcohol consumption and aINS OX1Rs drives nicotine intake.
In contrast, OX1Rs within the mPFC did promote alcohol
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FIGURE 7 | OX1R blockade within the medial NAc Shell significantly reduced operant alcohol drinking in rats. (A) Locations of cannulae shown by gray
circles; sections at approximately AP +1.70, +1.60, and +1.20 relative to Bregma. (B) Infusion of 3-µg SB within the mNAsh of rats decreased active lever presses for
alcohol. (C) No changes in inactive lever presses with SB. (D,E) OX1R inhibition in the mNAsh reduced (D) rewards received and (E) alcohol intake levels. *p < 0.05.
consumption. Further supporting the central role for mNAsh
OX1Rs in promoting alcohol drinking, OX1R inhibition within
the mNAsh of rats significantly reduced operant alcohol self-
administration. Finally, orexin application ex vivo significantly
enhanced action potential firing of mNAsh neurons from
alcohol-drinking mice, with no changes in input resistance or
evoked EPSCs. Together, our results suggest that the mNAsh
and mPFC, but not the aINS, are critical regions where OX1R
activation drives excessive alcohol drinking.
While a number of studies suggest that OX1Rs play a
prominent and selective role in responding for more motivating
rewards (See Section Introduction), very little is known about
the brain regions where OX1Rs act to promote excessive alcohol
drinking. Here, we did not assess motivation directly, but instead
examined the impact of orexin on drinking behaviors. Our
findings are important since they identify the mNAsh as a region
where OX1Rs drive alcohol consumption in both mice and rats.
In addition, our studies indicate that OX2Rs within the mNAsh
are not required to promote excessive alcohol consumption.
Previous work has implicated the mNAsh in different forms
of addictive and consummatory behaviors, including feeding
(Baldo et al., 2013; Richard et al., 2013) and alcohol drinking
(Kasten and Boehm, 2014; Lum et al., 2014; Wilden et al., 2014;
Ramaker et al., 2015). The mNAsh also promotes different forms
of reinstatement (Anderson et al., 2008), including for alcohol
(Chaudhri et al., 2010; Marchant et al., 2015), although, under
conditions of extinction, inhibiting the mNAsh promotes relapse
for alcohol (Millan et al., 2010). However, cortical activation of
the mNAsh promotes reinstatement of opiate conditioned place
preference (CPP) (Hearing et al., 2016) and seeking (Bossert et al.,
2015), and OXRs within the mNAsh also contribute to expression
and reinstatement of morphine CPP (Qi et al., 2013; Sadeghzadeh
et al., 2016). Thus, although the mNAsh contribution can vary
depending on the addictive behavior, these studies overall concur
with our findings that OX1Rs in the mNAsh promote alcohol
drinking in vivo and increase neuronal activity ex vivo (see
below).
In contrast to the central role for mNAsh OX1Rs in driving
alcohol consumption, OX1Rs within the aINS seemed to play no
role in alcohol drinking. This was surprising because the aINS
is thought to drive many addictive behaviors in both humans
(Naqvi et al., 2014) and animals (Hollander et al., 2008; Seif
et al., 2013), including compulsion-like alcohol drinking (Seif
et al., 2013), and OX1Rs within the aINS mediate nicotine
intake (Hollander et al., 2008). Thus, inasmuch as the aINS can
promote alcohol drinking, it is likely that signaling systems other
than OX1Rs within the aINS are required to promote addictive
behavior. Also, OX1Rs in the medial prefrontal cortex promote
cued reinstatement for alcohol in genetically-selected alcohol-
preferring rats (Brown R.M. et al., 2015). In agreement, we found
that mPFC OX1Rs were also important for promoting alcohol
intake. Thus, our studies have identified critical regions of the
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FIGURE 8 | OrexinA increased firing ex vivo in medial NAc Shell neurons from alcohol-drinking mice. (A) Example showing that 100 nM orexinA (OxA)
increased firing in the mNAsh neurons from adult alcohol-drinking mice; firing was evoked by 500-ms depolarizing current pulses (See Section Methods). Example is
from rheobase, the minimum current required to evoke firing, in this neuron (B,C) Averaged data showing the increased number of action potentials generated with
OxA (B) at rheobase, and (C) at the current step above rheobase, and that blocking OX1Rs with SB prevented the OxA increase in firing. *p < 0.05.
cortico-accumbens circuit where OX1Rs act to promote excessive
alcohol drinking.
Since the mNAsh can regulate feeding, including OXRs within
the mNAsh (Thorpe and Kotz, 2005; Urstadt and Stanley,
2015; but see Baldo and Kelley, 2001), the reduction of alcohol
consumption after inhibiting mNAsh OX1Rs could reflect more
general effects on motor and consumption. However, intra-
mNAshOX1R inhibition had no effect on saccharin consumption
or concurrent water intake during alcohol-drinking sessions,
suggesting that mNAsh OX1Rs play a more specific role in
driving alcohol consumption. In agreement, previous studies
found no change in chow intake or locomotor activity when
OX1Rs were inhibited in the mNAsh (Thorpe and Kotz, 2005;
Kotani et al., 2008; Qi et al., 2013). In addition, several studies
implicating the mNAsh in alcohol drinking also observed
no reduction in intake of sweet substances (Stratford and
Wirtshafter, 2011; Rewal et al., 2012; Kasten and Boehm, 2014;
Lum et al., 2014). Thus, although there was a trend for a
decrease in saccharin intake in our results with intra-mNAsh
SB infusion, it is more likely that this does not reflect an
actual but underpowered decrease. Also, we found that mNAsh
OX1R inhibition significantly reduced alcohol drinking but not
preference, which likely reflects the low level of concurrent water
intake during the alcohol access session (a similar pattern is also
observed in Dhaher et al., 2009; Seif et al., 2015; den Hartog
et al., 2016). Thus, while mNAsh signaling can contribute to
many consummatory behaviors, our findings suggest that OX1Rs
within the mNAsh play a particular role in promoting excessive
alcohol drinking.
In agreement with our observations that OX1R mNAsh
promoted excessive alcohol drinking, we found that the
orexin ex vivo enhanced action potential firing in mNAsh
neurons from alcohol-drinking mice, and that this orexin
increase in activity required OX1Rs. In contrast, there were
no changes in evoked glutamatergic EPSCs, perhaps suggesting
a primarily postsynaptic effect of orexin excitation within the
mNAsh. In addition, orexin increased evoked firing with no
changes in input resistance at the resting membrane potential.
Interestingly, enhancement in mNAsh firing without changes at
the hyperpolarized resting potential is similar to what has been
reported for dopamine enhancement of mNAsh firing (Hopf
et al., 2003). In agreement, NAc dopamine receptors regulate
alcohol drinking and seeking (Bahi and Dreyer, 2012; Hauser
et al., 2015), and dopamine receptors have been shown to interact
with orexin to enhance mNAsh firing ex vivo (Mori et al., 2011).
However, previous studies of orexin enhancement of mNAsh
firing suggest a role for OX2Rs (Mukai et al., 2009; Mori et al.,
2011), although these were performed in very young (12–16
d) animals, while our work was performed in adult neurons.
Also, we did not find a role for OX2Rs within the mNAsh
in promoting alcohol drinking. However, other work suggests
that OX2Rs can interact with OX1Rs under some conditions,
e.g., where either OX1R or OX2R inhibition in the mNAsh can
suppress reinstatement of morphine CPP (Qi et al., 2013). Also,
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FIGURE 9 | OrexinA ex vivo did not alter input resistance or evoked
EPSCs in medial NAc Shell neurons from alcohol-drinking mice. (A,B)
Examples (A) and grouped data (B) showing that OxA did not change input
resistance (30 pA hyperpolarizing step). (C) Plot across time showing that OxA
did not change evoked EPSCs at −70mV.
orexin enhancement of locomotion may be related to OX2Rs
but not OX1Rs in the mNAsh (Thorpe and Kotz, 2005; Kotani
et al., 2008), suggesting that mNAsh OX1Rs and OX2Rs can have
differential effects. Furthermore, passive high alcohol exposures
produce plasticity within the NAc Shell (Renteria et al., 2016), but
we found that orexin enhanced firing ex vivo without changes in
input resistance in both alcohol-drinking and alcohol-naïvemice.
Nonetheless, understanding the ex vivo impact of orexinA ismost
critical in alcohol drinkers, since this physiological impact would
be more relevant to the ability of mNAsh OX1Rs to drive alcohol
intake.
It is also important to understand whether the ability
of OX1Rs to enhance mNAsh postsynaptic firing, but not
glutamatergic activation, has a more general implication for
behavioral regulation by the mNAsh. Our observation that
OX1Rs increasedmNAsh activity and promoted alcohol drinking
are in overall agreement with previous studies using agents
that inhibit neuronal function, such as GABA receptor agonists,
where mNAsh inhibition decreases alcohol drinking (e.g.,
Stratford and Wirtshafter, 2011; Kasten and Boehm, 2014;
Ramaker et al., 2015). While these studies do not demonstrate
the postsynaptic function per se is the primary site of action,
it is very likely that the behavioral impact of these compounds
reflects inhibition of the NAc neuron activity that is known to
promote behavioral expression in a number of other paradigms
(e.g., McGinty et al., 2013; Pascoli et al., 2014). Thus, any
action of orexin (or other neurochemicals) that increases
activity of NAc neurons could promote behavioral expression
of alcohol drinking. In addition, enhancement of mNAsh firing
or glutamatergic activity could increase excitatory throughput
of the mNAsh and increase behavioral expression, especially
since NAc neurons postsynaptic firing is strongly dependent
on glutamatergic excitation (Gerfen and Surmeier, 2011). Thus,
while modulation of specific glutamatergic inputs to the mNAsh
could alter specific aspects of behavior (e.g., Pascoli et al., 2014),
it remains unclear what selective effects that overall modulation
of firing vs. glutamatergic activation would have. Finally, we
found that mNAsh OX1Rs did not significantly regulate intake
of saccharin, in agreement with other work finding no reduction
in intake of sweet substances after mNAsh inhibition (see above).
In fact, increased intake of sweet and other highly palatable
substances has been associated with strong inhibition of the
mNAsh rather than excitation (Richard et al., 2013). In contrast,
mNAsh OXRs have been associated with increased food intake in
some, although not all, studies (Baldo and Kelley, 2001; Thorpe
and Kotz, 2005; Urstadt and Stanley, 2015). Thus, the neuronal
pathway activated by mNAsh OX1Rs seems to play a more
selective impact on intake of certain substances (alcohol, food),
with perhaps a very different role for other substances (sweets);
this might provide insight into the specific consummatory
pathways co-opted by drives for alcohol.
It is important to note there have beenmixed results regarding
whether there are OX1Rs present in the NAshell and striatum,
and that the OX1R-related blocker SB can still impact OX2Rs,
although at lower affinity relative to OX1Rs (Smart et al.,
2001). Importantly, however, our intracranial pharmacology
experiments directly demonstrate that inhibition of OX1Rs but
not OX2Rs within the mNAsh significantly reduced excessive
alcohol drinking. These suggest that OX1Rs but not OX2Rs
within the mNAsh promote excessive drinking. Nonetheless,
while some studies have found some OX1R mRNA signal within
the medial NAc (D’Almeida et al., 2005) and striatum (Hervieu
et al., 2001, NAc not tested), others did not (Trivedi et al., 1998;
Marcus et al., 2001). Also, a recent study utilizing a transgenic
OX1R-GFP mouse found no OX1R-containing neurons within
the NAc (Ch’ng and Lawrence, 2015). We note that mRNA
levels do not always predict functional protein expression (e.g.,
as observed for OX1Rs for some brain regions described in Table
1 of Ch’ng and Lawrence, 2015). Also, small levels of receptor
expression may be sufficient to allow functional signaling. e.g.,
where overlap of DA1R-cell and DA2R-cell markers can be seen
in at least 20% of striatal neurons by electrophysiology and
the very sensitive single-cell RT-PCR (Surmeier et al., 1996),
even though transgenic GFP-expressing lines show very little
overlap of DA1R-cell and D2R-cell markers in striatal neurons
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(Gerfen and Surmeier, 2011). In addition, OxA infusion within
the mNAsh enhances feeding, which is prevented by SB, while
OxA enhancement of locomotion is not prevented by SB (Thorpe
and Kotz, 2005), indicating that SB can impact some but not
all effects of OxA within the mNAsh, the remainder presumably
reflecting action throughOX2Rs. Also, development ofmorphine
CPP is inhibited by SB but not OX2R inhibitors in the mNAsh
(Sadeghzadeh et al., 2016). Finally, other studies have provided
ex vivo evidence for functional OX1Rs within the mNAsh
(Patyal et al., 2012), in addition to our demonstration of OX1R-
dependent enhancement of mNAsh firing; we believe that these
electrophysiological measures provide the most sensitive and
direct method to assess the presence of functional receptors,
in this case OX1Rs. Thus, since we directly demonstrated that
inhibition of mNAsh OX2Rs with TCS had no impact on
excessive alcohol drinking, our results taken together suggest
that SB acts at OX1Rs within the mNAsh to suppress alcohol
drinking. In addition, it is clear that the ability of OxR signaling
to suppress alcohol drinking is region-specific, since both Insula
and regions dorsal to the NAshell have Ox1Rs and OX2Rs, but SB
within these regions had no impact on alcohol drinking. Finally,
although our rat and mouse results implicate OX1R signaling
within the mNAsh in promoting excessive alcohol drinking, we
cannot completely rule out the possibility that the impact of intra-
cranially infused SB inhibited alcohol drinking by action in a
regionmedial or lateral to the mNAsh, such as the septum or NAc
core. This is primarily a concern inmice, since we have previously
shown that intra-mNAsh infusion in rats does not lead to effects
within the adjacent NAc core, suggesting minimal effects of
diffusion (Hopf et al., 2010). Also, the septum contains Ox1Rs
although not mRNA for OX1Rs (see Wu et al., 2002; Ch’ng and
Lawrence, 2015), while addiction-related orexin signaling has
been associated with OX2Rs but not OX1Rs in the septum (Flores
et al., 2016), and OX2Rs in the NAc core can regulate alcohol-
related behavior (Brown et al., 2013). In contrast, here we found
that OX1Rs but not OX2Rs drove excessive alcohol drinking
in mice. Further experiments, perhaps involving local infusion
of inhibitory RNAs, will be required to fully dissociate whether
areas adjacent to the mNAsh are important for regulating alcohol
drinking.
Taken together, our studies indicate that OX1Rs within the
mNAsh are critical for promoting excessive alcohol drinking,
which may reflect the ability of orexin to increase action
potential firing in an OX1R-dependent manner in mNAsh
neurons from alcohol drinkers. In contrast, OX1Rs within
the aINS did not regulate alcohol consumption, even though
the aINS can regulate alcohol intake (Seif et al., 2013)
and aINS OX1Rs can promote nicotine intake (Hollander
et al., 2008). Since OX1Rs play a predominant role in
driving motivated intake (see above), and excessive drinking
in humans is driven by pathological drives for alcohol, our
results suggest that the mNAsh is a key region where OX1Rs
can promote excessive alcohol intake. Thus, OX1R inhibitors
might represent a viable therapeutic intervention to suppress
alcohol drinking in humans (Khoo and Brown, 2014; Li et al.,
2016).
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